Products & ReviewLife Sciences
Twist Human Anti-ACE2 Antibodies
Twist Biopharma has developed a set of antibodies that targets the SARS-CoV-2 Spike Protein with high binding affinity and specificity. Several antibodies also show the ability to block S1 binding to ACE2.
The human anti-ACE2 receptor antibodies exhibit high affinity to the ACE2 receptor indicating that they have the potential to be developed as blocking or competitive antibodies for therapeutic applications.